Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Best Peptides to Recover From Injury Faster Ranked: Efficacy Comparison

| Peptide | Primary Mechanism | Best For | Evidence Strength | Typical Protocol | Limitations | Professional Assessment ||—|—|—|—|—|—|| BPC-157 | VEGF-driven angiogenesis, FAK-paxillin activation | Tendons, ligaments, muscle, bone, GI tissue | 18+ preclinical

This comparison does not assign a generated winner or score.

  • | Peptide | Primary Mechanism | Best For | Evidence Strength | Typical Protocol | Limitations | Professional Assessment ||—|—|—|—|—|—|| BPC-157 | VEGF-driven angiogenesis, FAK-paxillin activation | Tendons, ligaments, muscle, bone, GI tissue | 18+ preclinical trials, 40–65% healing time reduction | 250–500 mcg daily, 4–8 weeks, local injection | No human Phase 3 trials, research-only status | Most versatile. Broadest injury type efficacy || TB-500 | Actin regulation, cell migration, anti-fibrotic | Muscle strains, post-surgical adhesions, scar prevention | 8 preclinical trials, 40% scar reduction in muscle | 2.0–2.5 mg twice weekly (loading), then weekly | Limited angiogenesis, slower for vascular injuries | Best for minimising fibrosis and improving range of motion || IGF-1 LR3 | Satellite cell activation, mTOR pathway stimulation | Muscle tears, post-surgical atrophy, hypertrophy during rehab | Strong mechanistic data, limited injury-specific human trials | 40–80 mcg daily, 4 weeks o